Wade Hull

Wade Hull

Chief Tech/Sci/R&D Officer at CRESCITA THERAPEUTICS INC.

Net worth: 11 618 $ as of 28/02/2024

Health Technology
Consumer Services

Profile

Wade Hull is currently the Vice President-Research & Development at Nuvo Pharmaceuticals, Inc. and Crescita Therapeutics, Inc. He previously worked as the Principal at Utah Medical Products, Inc. and as the Vice President-Research & Development at ZARS Pharma, Inc. Mr. Hull completed his undergraduate and graduate degrees at the University of Utah.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
27/12/2023 39,384 ( 0.20% ) 11 618 $ 28/02/2024

Wade Hull active positions

CompaniesPositionStart
CRESCITA THERAPEUTICS INC. Chief Tech/Sci/R&D Officer 29/02/2016
NUVO PHARMACEUTICALS INC. Chief Tech/Sci/R&D Officer -
All active positions of Wade Hull

Former positions of Wade Hull

CompaniesPositionEnd
UTAH MEDICAL PRODUCTS, INC. Corporate Officer/Principal 30/11/1996
Chief Tech/Sci/R&D Officer -
See the detail of Wade Hull's experience

Training of Wade Hull

University of Utah Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Wade Hull's experience

Connections

32

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
UTAH MEDICAL PRODUCTS, INC.

Health Technology

CRESCITA THERAPEUTICS INC.

Health Technology

Private companies2

Health Technology

Health Technology

See company connections